MERGE microbial strain improvement technique
MERGE uses non-GMO techniques to turn probiotics into therapeutics and reliable, commercial strains
MERGE is a patented strain improvement technique which used a type of directed evolution resulting in new phenotypes and antimicrobials. It turns mediocre results into repeatable and reliable results.
SciBac has used MERGE to create 2 novel lung therapeutics with multiple mechanisms designed to clear chronic lung infections in cystic fibrosis.
Technology:
Microorganisms:
Application:
Development stage:
- Infection prevention
- Antimicrobial stewardship
- Alternative antimicrobials
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Fungi
- Yeasts
- Parasites
- Viruses
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:WordPress › Error
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Joint Venture
- Sell
- Outsource
Funding organisation: